Skip to main content

Table 6 Liver function parameters of patients with tumor burden within Milan criteria (n = 135) on the basis of performance status

From: TACE performed in patients with a single nodule of Hepatocellular Carcinoma

Variable

PS-0 (n = 120)

PS-1 (n = 15)

P

Ascites, n (%)

  

1.000

  Absent

98 (82)

12 (80)

 

  Present

22 (18)

3 (20)

 

Encephalopathy, n (%)

  

0.300

  Absent

118 (98)

14 (93)

 

  Slight

2 (2)

1 (7)

 

Serum total bilirubin, median (mg/dL) (range)

1.39 (0.30 – 10.67)

1.23 (0.53 – 7.72)

0.817

Serum albumin, median (g/dL) (range)

3.60 (2.40 – 5.00)

3.60 (2.80 – 4.90)

0.596

Serum INR, median (range)

1.28 (1.00 – 1.97)

1.23 (1 – 1.86)

0.535

Serum creatinine, median (range)

0.92 (0.50 – 1.73)

0.78 (0.65 – 1.66)

0.115

Hepatic function, n (%)

  

0.784

  CPT-A

74 (62)

10 (67)

 

  CPT-B

46 (38)

5 (33)

 

Hepatic function, n (%)

  

0.655

  CPT-A5

54 (45)

6 (40)

 

  CPT-A6

20 (17)

4 (27)

 

  CPT-B7

22 (18)

1 (7)

 

  CPT-B8

19 (16)

2 (13)

 

  CPT-B9

5 (4)

2 n

 
  1. Abbreviations: CPT Child-Pugh-Turcotte score, INR international normalized ratio.